Jeremy Bender - Net Worth and Insider Trading
Jeremy Bender Net Worth
The estimated net worth of Jeremy Bender is at least $22 Million dollars as of 2024-12-26. Jeremy Bender is the CHIEF EXECUTIVE OFFICER of Day One Biopharmaceuticals Inc and owns about 1,717,215 shares of Day One Biopharmaceuticals Inc (DAWN) stock worth over $22 Million. Details can be seen in Jeremy Bender's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Jeremy Bender has not made any transactions after 2024-11-18 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Jeremy Bender
Jeremy Bender Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Jeremy Bender owns 2 companies in total, including Day One Biopharmaceuticals Inc (DAWN) , and Fusion Pharmaceuticals Inc (FUSN) .
Click here to see the complete history of Jeremy Bender’s form 4 insider trades.
Insider Ownership Summary of Jeremy Bender
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| DAWN | Day One Biopharmaceuticals Inc | 2024-11-18 | director & Chief Executive Officer |
| FUSN | Fusion Pharmaceuticals Inc | 2023-10-16 | director |
Jeremy Bender Latest Holdings Summary
Jeremy Bender currently owns a total of 1 stock. Jeremy Bender owns 1,717,215 shares of Day One Biopharmaceuticals Inc (DAWN) as of November 18, 2024, with a value of $22 Million.
Latest Holdings of Jeremy Bender
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| DAWN | Day One Biopharmaceuticals Inc | 2024-11-18 | 1,717,215 | 12.87 | 22,100,557 |
Holding Weightings of Jeremy Bender
Jeremy Bender Form 4 Trading Tracker
According to the SEC Form 4 filings, Jeremy Bender has made a total of 23 transactions in Day One Biopharmaceuticals Inc (DAWN) over the past 5 years, including 0 buys and 23 sells. The most-recent trade in Day One Biopharmaceuticals Inc is the sale of 10,554 shares on November 18, 2024, which brought Jeremy Bender around $139,418.
Insider Trading History of Jeremy Bender
- 1
Jeremy Bender Trading Performance
Jeremy Bender Ownership Network
Jeremy Bender Owned Company Details
What does Day One Biopharmaceuticals Inc do?
Who are the key executives at Day One Biopharmaceuticals Inc?
Jeremy Bender is the director & Chief Executive Officer of Day One Biopharmaceuticals Inc. Other key executives at Day One Biopharmaceuticals Inc include Chief Medical Officer Samuel C. Blackman , COO & CFO and Secretary York Charles N Ii , and 10 percent owner Ai Day 1 Llc .
Day One Biopharmaceuticals Inc (DAWN) Insider Trades Summary
Over the past 18 months, Jeremy Bender made 7 insider transaction in Day One Biopharmaceuticals Inc (DAWN) with a net sale of 122,037. Other recent insider transactions involving Day One Biopharmaceuticals Inc (DAWN) include a net sale of 240,340 shares made by Samuel C. Blackman , a net sale of 72,915 shares made by York Charles N Ii , and a net sale of 18,175 shares made by Adam Dubow .
In summary, during the past 3 months, insiders sold 88,527 shares of Day One Biopharmaceuticals Inc (DAWN) in total and bought 0 shares, with a net sale of 88,527 shares. During the past 18 months, 463,467 shares of Day One Biopharmaceuticals Inc (DAWN) were sold and 1,475,454 shares were bought by its insiders, resulting in a net purchase of 1,011,987 shares.
Day One Biopharmaceuticals Inc (DAWN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Day One Biopharmaceuticals Inc Insider Transactions
Jeremy Bender Mailing Address
Above is the net worth, insider trading, and ownership report for Jeremy Bender. You might contact Jeremy Bender via mailing address: 395 Oyster Point Blvd., Suite 217, South San Francisco Ca 94080.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
